Mesothelioma: open trials in Japan

• NCT05579366

  Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  Trial Treatment · Phase 1/2 · Genmab

  Hyogo Cancer Center, Akashi · Fukushima Medical University Hospital, Fukushima · Saitama Medical University International Medical Center, Hidaka · Cancer Institute Hospital of JFCR, Koto · Shizuoka Cancer Center, Nagaizumi-chō · Gunma Prefectural Cancer Center, Ōta · Sapporo Medical University Hospital, Sapporo · Keio University Hospital, Shinjuku-ku · Yamagata University Hospital, Yamagata

  Registry updated 2026-11-04

• NCT06535607

  Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

  Trial Treatment · Phase 2 · AstraZeneca

  Kashiwa · Yokohama

  Registry updated 2026-09-11

• NCT06603987

  Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

  Trial Treatment · Phase 1/2 · Stella Pharma Corporation

  ORIX Kouraibashi Bldg. 8F 3-2-7 Kouraibashi Chuo-ku, Osaka

  Registry updated 2025-11-19

All Mesothelioma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error